OOIR: Observatory of International Research

Papers

(The H4-Index of Alzheimers & Dementia is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
CT1812 biomarker signature from a meta‐analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease	1885
Do the extracellular vesicles excreted during neuronal cell death play a neuron‐glia signalling role in neurodegeneration.	1617
Speed of cognitive decline in biomarker stratified SCD subgroups	721
Automating the verbal paired associates test to assess memory remotely and at scale	525
CaMKIIα signaling is required for the neuroprotective effects of Dl‐3‐n‐butylphthalide in Alzheimer’s disease	508
2021 Annual Report of Japanese Brain Bank Network for Neuroscience Research	437
Systemic and central nervous system metabolome changes associated with Ginkgo biloba treatment in non‐demented subjects	348
Characteristics of peripheral immune system in a novel App^NL‐G‐F knock‐in mouse model of Alzheimer’s disease	236
AD‐Associated Variants Directly Impair Surface Interactions Between the Hydrophobic Site of TREM2 and the Hinge Region of ApoE	234
Loss of apolipoprotein E exacerbates microglial and astrocyte reactivity to sustained systemic glucocerebrosidase inhibition	201
Validation of Mitochondria‐Targeted AD Therapeutics in Human Neuronal Cells	164
Assessment of ccf‐Mitochondrial DNA Damage in Cognitive Impairment via NGS: Health Disparities in Mexican Americans	159
Exploring Inflammasome/Cytokine/Insulin cascade as converging landscape for AD, Schizophrenia(SCHIZO), and COVID‐19 syndrome: synthesis of evidence and Post‐hoc analysis of Ginsans‐115 RCT in treatmen	156
Characterization of a mouse model as a predictive tool for human Post‐Acute Sequelae of Covid‐19	155
Trajectories of Neurological Recovery 12 Months after Hospitalization for COVID‐19: A Prospective Longitudinal Study	147
The Effect of COVID‐19 Lockdown on Dementia Caregivers in the U.S.	145
Differential roles of ApoE isoforms in regulation of inflammatory cytokine expression	145
Using an entorhinal cortex‐based virtual reality navigation task to differentiate between individuals with and without subjective cognitive decline	139
Family care partners experiences of delirium in caring for a person with dementia: Qualitative descriptive study	138
Re‐evaluation of the genetic role of a rare APOE variant (L28P; APOE^4Pittsburgh*) in late‐onset Alzheimer disease	129
Methods in Prioritizing Pathways and Targets from Expression Data	124
Ancestry‐Specific eQTL Associations in AA/NHW Alzheimer Disease Cohorts	119
Association of air quality reduction with incident dementia: Effects of natural course and hypothetical air pollutant interventions using g‐computation	118
Policy recommendations from the perspective of health professionals who work with people with dementia in public tertiary hospitals in China	118
Iron intake, brain iron, and Alzheimer’s disease among community‐dwelling older adults	115

Assessing sex differences between mid‐life cardiovascular conditions or risk factors and mid‐life cognition decline	115
Outreach and recruitment of African Americans for Alzheimer’s disease studies during the COVID‐19 pandemic	112
Association of anticholinergic medication and AD biomarkers among cognitively normal late middle‐age adults: Results from the Wisconsin Registry for Alzheimer's Prevention (WRAP)	108
Biomarker driven enrichment strategies for tau pathology in AD clinical trials	106
Measuring synaptic loss in early AD stages: Trajectories of SNAP25 and SYT1 using serial CSF sampling	103
Comparison of remote and in‐person digital speech‐based measures of cognition	103
Dementia‐inclusive radio series ‘Talkin’ About Neurodegeneration'—A look under the dementia umbrella and a follow‐on series to award‐winning ‘Voyage Around My Brain’ on NearFM	103
Associations between CSF proteins and medial temporal lobe atrophy across the AD continuum	102
Persistent pain is associated with lower locus coeruleus integrity in older adults	95
Issue Information	91
The use of the Cognitive Change Questionnaire by community health workers as dementia screening method	88
Applications of PRESS‐MRS, MEGA‐PRESS, and pCASL to evaluate treatment effect of Kami Guibi‐tang on amnestic MCI	84
Fish intake and MRI burden of cerebrovascular disease in older adults	82
Concordance and diagnostic accuracy between Innotest and two fully automated platforms: Elecsys and Lumipulse	82
Exploring the basis of phenotypic diversity in Alzheimer’s disease	79
Technical performance and biotemporal stability evaluation of Olink proximity extension assay for blood‐based biomarker discovery	79
Tracing individual trajectory of longitudinal tau spreading in deep latent space	78
Identifying individuals with non‐AD co‐pathologies: A precision medicine approach to clinical trials in sporadic AD	75
The troubles and needs of family caregivers of older adults with moderate to severe dementia	72
Meaning from tragedy: exploring attitudes toward dementia patient participation in research	72
Impairment of auditory integration in subjective cognitive decline, amnestic mild cognitive impairment, and Alzheimer’s disease	70
Feasibility of the occupational therapy protocol TAP (Tailored Activity Program) for the management of behaviors in a dementia hospital unit: Preliminary results from a pilot study	68
Cognitive correlations with amyloid, tau and neurodegeneration PET across the Alzheimer’s disease age spectrum	67
Combination of baicalein and trans‐chalcone synergistically reduces amyloid beta and its toxicity in yeast	67
Cortical microstructure is associated with tau burden and predicts cognitive decline and clinical progression in healthy older adults	63
Networking analysis for neuroimaging and genetic markers in Alzheimer's disease	61
The chauffeur who banged cars happily: an interesting case of rapidly progressive strategic infarct dementia	60
Despite heightened risk of cognitive decline, no evidence of local atrophy in people with subjective cognitive decline compared to normal controls in ADNI	60
The relationship between cortical grey to white matter signal contrast (GWC) and tau pathology in atypical AD	59
The heterogeneity of subjective cognitive decline: A data‐driven approach on a population‐based sample	57
Functional connectivity measurements in APP/PS‐1 mice revealed hypo‐connectivity with transient hyper‐connectivity	57
Visual memory test equal to commonly used verbal memory test in predicting tau in the medial temporal lobe	56
Trajectories of self‐rated concerns in individuals developing cognitive decline	56